Despite facing declining sales, Smith Micro Software's stock has demonstrated unexpected resilience in recent trading. The company's second quarter 2025...

A prominent law firm has initiated a formal investigation into Marinus Pharmaceuticals on behalf of long-term shareholders, creating significant legal...

The shares of clinical-stage biopharmaceutical company Annovis Bio continue their downward trajectory, creating a stark contrast with the unwavering bullish...

Alibaba's recent surge to a four-year peak proved short-lived as the technology rally showed signs of fatigue. After reaching unprecedented...

The transformation of Ocuphire Pharma into Opus Genetics represents more than a simple rebranding—it marks a fundamental strategic shift with...

After navigating a challenging period marked by cybersecurity incidents, rising operational expenses, and significant profit warnings, UnitedHealth Group is showing...

The investment case for Edap TMS presents a curious contradiction. On one hand, the company's Focal-One HIFU technology for treating...

As Nvidia continues to command the artificial intelligence market, Advanced Micro Devices (AMD) is executing a distinct strategy to carve...

A significant shift in US renewable energy policy, driven by the newly enacted "One Big Beautiful Bill Act" (OBBBA), is...

After years of financial struggles, Plug Power is demonstrating tangible signs of a significant operational turnaround. The hydrogen fuel cell...